![La versión española del BASDAI es fiable y se correlaciona con la actividad de la enfermedad | Revista Española de Reumatología La versión española del BASDAI es fiable y se correlaciona con la actividad de la enfermedad | Revista Española de Reumatología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13064152:29v31n06-13064152tab05.gif?idApp=UINPBA00004N)
La versión española del BASDAI es fiable y se correlaciona con la actividad de la enfermedad | Revista Española de Reumatología
![POCKET.MD - Pfizer Rheumatology Calculator, This rheumatology disease activity calculator has been developed to quickly and easily measure the d... POCKET.MD - Pfizer Rheumatology Calculator, This rheumatology disease activity calculator has been developed to quickly and easily measure the d...](http://www.pocket.md/images/appImages/screenshots/1305599769.jpg)
POCKET.MD - Pfizer Rheumatology Calculator, This rheumatology disease activity calculator has been developed to quickly and easily measure the d...
BASDAI Por favor, marque con una X el recuadro que representa su respuesta ( ejemplo ) Todas las preguntas se refieren a la últ
![SciELO - Brasil - Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura SciELO - Brasil - Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura](https://minio.scielo.br/documentstore/1809-4570/XjzkYynPfDVbzMLPfJGHzQR/917a6e36eccdfd590a9a49a84f3640044a85d7c8.gif)
SciELO - Brasil - Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura Medidas de avaliação clínica em pacientes com espondilite anquilosante: revisão da literatura
![PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study](https://i1.rgstatic.net/publication/349041855_Low_BASDAI_score_alone_is_not_a_good_predictor_of_anti-tumor_necrosis_factor_treatment_efficacy_in_ankylosing_spondylitis_a_retrospective_cohort_study/links/601d53db299bf1cc26a6b2d8/largepreview.png)
PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study
![Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-020-03941-8/MediaObjects/12891_2020_3941_Fig1_HTML.png)